ArticlePharmacoEconomics2021
Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden.
Article in PharmacoEconomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Pooled it
- Economic Impact of Insufficient and Disturbed Sleep in the Workplace.PharmacoEconomics · 2023Pooled it
- Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.Advances in nutrition (Bethesda, Md.) · 2022Pooled it
- Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026Article
- Societal and Economic Impact of Informal Caregiving for Musculoskeletal Conditions: A Productivity-Adjusted Life Year (PALY) Study.Journal of occupational rehabilitation · 2026Article
- The Health and Productivity Impact of Thyroid Diseases Among Working-Age Women in Western Europe.International journal of women's health · 2026Article
- Productivity-adjusted life year loss among the late middle-aged adults in China.Communications medicine · 2025Article
- Microbiome and Heart Failure: A Comprehensive Review of Gut Health and Microbiota-Derived Metabolites in Heart Failure Progression.Medical sciences (Basel, Switzerland) · 2025Review
- Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications.PharmacoEconomics · 2025Article
- Sickness absences and losses in productivity-adjusted life years before, during and after the most common orthopedic surgical procedures among employed individuals in Finland.BMC health services research · 2025Observational
- Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention.PharmacoEconomics · 2025Review
- Development of novel DALY-based indices for assessing productivity loss and resource allocation for liver cancer in the MENA region.Population health metrics · 2025Article
- Ten-year projection of adult epilepsy burden in Australia.Epilepsia · 2025Article
- Productivity Losses Due to Long-Term Back Problems in Working-Age Australians.JAMA network open · 2025Article
- Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling study.The Lancet regional health. Western Pacific · 2025Article
- Unraveling the future productivity burden of cardiovascular disease in Qatar: Investigating the modifiable risk factors control in type 2 diabetes.American journal of preventive cardiology · 2025Article
- Fixation stability and stress redistribution following metal block use in opening-wedge high tibial osteotomy: a finite element analysis.Frontiers in bioengineering and biotechnology · 2025Article
- Economic impact of screening on postdiagnosis work productivity in Japanese women with breast cancer: a life-table modeling approach.Breast cancer (Tokyo, Japan) · 2025Article
- Article
- The Burden of Type 2 Diabetes on the Productivity and Economy in Sub-Saharan Africa: A Life Table Modelling Analysis from a South African Perspective.PharmacoEconomics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.